EU probes France's Sanofi over vaccines business practices
Briefly

EU probes France's Sanofi over vaccines business practices
"The European Commission said it had carried out surprise inspections of a company active in the vaccines sector. It did not name the firm, nor say in which country the raids were taking place, though it specified investigators were joined by competition authorities of the member state affected. The European Commission said it has "concerns that the inspected company may have violated EU antitrust rules that prohibit abuses of a dominant market position"."
"In a statement, Sanofi said it "confirms that representatives of the European Commission visited Sanofi's headquarters in France and Germany on September 29, 2025, as part of an investigation into its conduct in the seasonal flu vaccine sector". Sanofi said it was confident that it had "complied with the relevant rules and regulations". The Commission indicated it was in particular looking into alleged anti-competitive disparagement, in which companies talk down the products of rivals."
The European Commission carried out surprise inspections at a vaccines company amid concerns about possible violations of EU antitrust rules, including abuses of a dominant market position. Sanofi confirmed that Commission representatives visited its headquarters in France and Germany on September 29, 2025, and said it is confident it complied with relevant rules and regulations. The probe focuses in part on alleged anti-competitive disparagement, where firms talk down rivals' products. Surprise inspections are a preliminary investigatory step and do not imply guilt. Flu vaccines represent a major business for Sanofi and face competition from companies such as Viatris and CSL Seqirus.
Read at The Local France
Unable to calculate read time
[
|
]